Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Santi Rello-Varona"'
Autor:
Roser López-Alemany, Santi Rello-Varona, Nuria Mulet-Margalef, Xavier Garcia del Muro, Oscar M. Tirado, Miriam Fuentes-Guirado, Silvia Garcia-Monclús, Aida Contreras-Pérez
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Soft-tissue sarcomas (STS) are an uncommon and heterogeneous group of malignancies that result in high mortality. Metastatic STS have very bad prognosis due to the lack of effective treatments. Dinaciclib is a model drug for the family of CDK inhibit
Autor:
Santi Rello-Varona, Olga Almacellas-Rabaiget, Roser López-Alemany, Jaume Mora, Piedad Alba-Pavón, Enrique de Álava, Juan Huertas-Martinez, Lourdes Hontecillas-Prieto, Silvia Garcia-Monclús, David Herrero-Martin, Laura Lagares-Tena, Paloma H. Giangrande, O.M. Tirado
Publikováno v:
International Journal of Cancer. 143:1188-1201
Ewing sarcoma (ES) is the second most common bone malignancy affecting children and young adults with poor prognosis due to high metastasis incidence. Our group previously described that EphA2, a tyrosine kinase receptor, promotes angiogenesis in Ewi
Autor:
Santi, Rello-Varona, Miriam, Fuentes-Guirado, Roser, López-Alemany, Aida, Contreras-Pérez, Núria, Mulet-Margalef, Silvia, García-Monclús, Oscar M, Tirado, Xavier, García Del Muro
Publikováno v:
Scientific Reports
Soft-tissue sarcomas (STS) are an uncommon and heterogeneous group of malignancies that result in high mortality. Metastatic STS have very bad prognosis due to the lack of effective treatments. Dinaciclib is a model drug for the family of CDK inhibit
Autor:
O.M. Tirado, Santi Rello-Varona
Publikováno v:
Pharmacogenomics. 18:1307-1309
Autor:
Silvia, Garcia-Monclús, Roser, López-Alemany, Olga, Almacellas-Rabaiget, David, Herrero-Martín, Juan, Huertas-Martinez, Laura, Lagares-Tena, Piedad, Alba-Pavón, Lourdes, Hontecillas-Prieto, Jaume, Mora, Enrique, de Álava, Santi, Rello-Varona, Paloma H, Giangrande, Oscar M, Tirado
Publikováno v:
International journal of cancer. 143(5)
Ewing sarcoma (ES) is the second most common bone malignancy affecting children and young adults with poor prognosis due to high metastasis incidence. Our group previously described that EphA2, a tyrosine kinase receptor, promotes angiogenesis in Ewi
Autor:
Santi Rello-Varona, Ana Casadó, M. L. Sagristá, Pilar Acedo, Margarita Mora, Magdalena Cañete, Angeles Villanueva, Juan C. Stockert
Publikováno v:
Repositorio Institucional del Instituto Madrileño de Estudios Avanzados en Nanociencia
instname
instname
Irinotecan (CPT-11) is an effective chemotherapeutic agent widely used to treat different cancers. Otherwise, the liposomal delivery of anti-tumor agents has been shown to be a promising strategy. The aim of this study has been to analyze the effect
Autor:
Santi Rello-Varona, O Almacellas Rabaiget, Juan Huertas-Martinez, David Herrero-Martin, O.M. Tirado, R. López-Alemany, Silvia Garcia-Monclús, Laura Lagares-Tena
Publikováno v:
Klinische Pädiatrie. 228
Autor:
Miguel Sáinz-Jaspeado, O.M. Tirado, Franck Court, E de Álava, Sebastian Moran, M A Peinado, Santi Rello-Varona, Raquel Buj, Juan Huertas-Martinez, David Herrero Martin, Jaume Mora, Silvia Garcia-Monclús, Manel Esteller, Javier Alonso
Publikováno v:
Klinische Pädiatrie. 228
Autor:
Nuria Mulet, Roser López-Alemany, Miriam Fuentes-Guirado, Oscar M. Tirado, Silvia Garcia-Monclús, Xavier Garcia del Muro, Aida Pérez-Contreras, Santi Rello-Varona
Publikováno v:
Journal of Clinical Oncology. 36:11582-11582
11582Background: Soft tissue sarcomas (STSs) present high mortality rates when metastatic and therefore identification of new active therapies is needed. Dinaciclib is a promising CDK inhibitor und...
Publikováno v:
Lasers in Surgery and Medicine. 41:665-673
Department of Chemistry, Bowling Green State University, Bowling Green, OhioBackground and Objectives: Photothermal sensitisa-tion has been recently proposed as a novel approach forthetreatment ofsolidtumours through the development ofa therapeutic m